DF Dent & Co. Inc. cut its holdings in Endava plc (NYSE:DAVA – Free Report) by 8.7% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 709,737 shares of the company’s stock after selling 67,371 shares during the quarter. DF Dent & Co. Inc. owned about 1.20% of Endava worth $21,931,000 as of its most recent SEC filing.
Other large investors have also bought and sold shares of the company. Assetmark Inc. lifted its stake in Endava by 93.1% in the fourth quarter. Assetmark Inc. now owns 985 shares of the company’s stock valued at $30,000 after buying an additional 475 shares in the last quarter. Blue Trust Inc. lifted its position in Endava by 28.5% in the 4th quarter. Blue Trust Inc. now owns 1,494 shares of the company’s stock valued at $46,000 after acquiring an additional 331 shares in the last quarter. GAMMA Investing LLC boosted its stake in Endava by 86.4% in the 4th quarter. GAMMA Investing LLC now owns 1,607 shares of the company’s stock worth $50,000 after purchasing an additional 745 shares during the period. PNC Financial Services Group Inc. increased its holdings in Endava by 60.4% during the 4th quarter. PNC Financial Services Group Inc. now owns 4,086 shares of the company’s stock worth $126,000 after purchasing an additional 1,538 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. acquired a new stake in shares of Endava in the 4th quarter valued at about $215,000. 62.23% of the stock is owned by institutional investors.
Endava Stock Performance
Shares of DAVA opened at $19.52 on Thursday. The company has a market cap of $1.15 billion, a PE ratio of 177.45, a price-to-earnings-growth ratio of 2.26 and a beta of 1.42. The firm has a 50-day moving average of $26.60 and a 200-day moving average of $27.59. Endava plc has a one year low of $18.84 and a one year high of $37.16. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.90 and a quick ratio of 1.90.
Wall Street Analyst Weigh In
A number of research analysts recently issued reports on the company. Morgan Stanley increased their price objective on Endava from $33.00 to $35.00 and gave the stock an “equal weight” rating in a report on Friday, January 31st. Needham & Company LLC decreased their price target on shares of Endava from $43.00 to $38.00 and set a “buy” rating for the company in a research note on Friday, February 21st. Finally, Susquehanna lowered their price objective on shares of Endava from $55.00 to $50.00 and set a “positive” rating on the stock in a report on Friday, February 21st. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $39.10.
Get Our Latest Research Report on DAVA
Endava Company Profile
Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.
See Also
- Five stocks we like better than Endava
- Dividend Capture Strategy: What You Need to Know
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- What is a penny stock? A comprehensive guide
- The 3 Most Talked About Investments on WallStreetBets Right Now
- What Are Dividend Contenders? Investing in Dividend Contenders
- Analyst Targets Signal More Growth in CrowdStrike Stock
Want to see what other hedge funds are holding DAVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Endava plc (NYSE:DAVA – Free Report).
Receive News & Ratings for Endava Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endava and related companies with MarketBeat.com's FREE daily email newsletter.